Therapeutic Hypothermia After Cardiac Arrest

John McPherson

TACT2 – Does Chelation Reduce Events in Diabetic Post-MI Patients?

Canadian Collaborative Research Network

N. Singh

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

ECMO for Refractory Cardiac Arrest: Mobile MN Community Efforts and …

University of Minnesota

D. Yannopoulos

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

ESC 2024 Insights: Major Adverse Cardiovascular Events, New Diagnose…

ESC 2024 Insights

M. Böttcher

Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…

UChicago Medicine

S. Nathan

ACC 2022: High Sensitivity Troponin in the Evaluation of Acute Chest…

ACC 2022 Conference Coverage

A. Jaffe

ESC 2024 Insights: Short- and Long-Term Effects of Beta-blockers on …

ESC 2024 Insights

P. Leissner

ECPR Criteria and Prognostication

University of Minnesota

J. Bartos

12 Lead EKG: Call the Interpreter

Scottsdale Interventional Forum 2023

S. Pathak

Cardiogenic Shock: All Mechanical Circulatory Support Devices

Complex Coronary Cases

G. Serrao